Showing results (141-150 of 166) with videos related to
Sort By:
Pageof 17
Journal of the National Cancer Center|July 22, 2024
The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapyTao Zhang, Jianyang Wang, Daquan Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Spatially resolved metabolomics to discover tumor-associated metabolic alterationsChenglong Sun, Tiegang Li, Xiaowei Song, et al.JAMA Oncology|June 24, 2021
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical TrialZhouguang Hui, Yu Men, Chen Hu, et al.The Oncologist|September 16, 2016
Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation TherapyJingbo Wang, Zongmei Zhou, Jun Liang, et al.Cancers|October 14, 2022
A Single Center Analysis of Thymic Neuroendocrine TumorsYirui Zhai, Qiang Zeng, Nan Bi, et al.JAMA Network Open|December 19, 2019
Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical TrialNan Bi, Jun Liang, Zongmei Zhou, et al.Journal of Cancer|June 18, 2019
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain MetastasesChunyu Wang, Xiaotong Lu, Zongmei Zhou, et al.Med (New York, N.Y.)|June 9, 2026
Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitisXiaoxiang Zhou, Ziming Jiang, Yanhong Ren, et al.Therapeutic Advances in Medical Oncology|February 16, 2026
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort studyQi Liu, Junqiang Chen, Wenbin Shen, et al.Therapeutic Advances in Medical Oncology|November 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter studyYu Lin, Wenbin Shen, Jinjun Ye, et al.Pageof 17